Dupilumab Faces Trial in Chronic Hives - Top_Thought_Leaders - MDSpire

Dupilumab Faces Trial in Chronic Hives

Phase III CUPID-C trial evaluates biologic therapy in patients with chronic spontaneous urticaria uncontrolled by antihistamines.

  • By

  • Kathryn Wighton

  • March 12, 2026

  • 5 min

Share

Top Thought Leaders in General Medicine

Brief introduction explaining scope and methodology.

Original Source(s)

Dupilumab Faces Trial in Chronic Hives

  • by Kathryn Wighton

  • March 12, 2026

Related Content

Medical Oddities: Ancient Practice Calms Modern BP

Ancient workouts, anxious ears, tea gains, limb regrowth, and furry tongues collide.

Atopic Dermatitis Treatment Targets Defined

Consensus definitions for disease control in atopic dermatitis aim to standardize clinical trial end points and support treat-to-target strategies.

Therapies for Infantile Haemangiomas: Current Practice and Evolving Perspectives